Literature DB >> 9434270

Functional and molecular characteristics of Na(+)-dependent nucleoside transporters.

J Wang1, M E Schaner, S Thomassen, S F Su, M Piquette-Miller, K M Giacomini.   

Abstract

Nucleoside transporters play a critical role in the absorption, disposition, and targeting of therapeutically used nucleosides and nucleoside analogs. This review is focused on the Na(+)-dependent, concentrative nucleoside transporters which are found in a variety of cells including renal, intestinal and hepatic epithelia. Five major Na(+)-dependent nucleoside transporter subtypes have been characterized in isolated tissue preparations: N1 is purine selective; N2 is pyrimidine selective and N3-N5 exhibit variable selectively for both purine and pyrimidine nucleosides. The recent cloning of N1 and N2 nucleoside transporters has provided the first information on the molecular function and structure of concentrative nucleoside transporters. In this manuscript we review the characteristics of the various subtypes of nucleoside transporters and the molecular structure, functional properties, and tissue distribution of the cloned Na(+)-dependent nucleoside transporters. In addition, the interactions of nucleosides and nucleoside analogs with the cloned transporters in mammalian and amphibian expression systems are presented. Mammalian expression systems may be particularly useful during drug development in screening potential compounds for improved bioavailability and tissue specific targeting. Finally, we present our view of future ares of study in the field of nucleoside transporters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434270     DOI: 10.1023/a:1012113931332

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

1.  Transport characteristics of renal brush border Na(+)- and K(+)-dependent uridine carriers.

Authors:  C W Lee; C I Cheeseman; S M Jarvis
Journal:  Am J Physiol       Date:  1990-05

2.  Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Two transport systems with differing substrate specificities.

Authors:  D Vijayalakshmi; J A Belt
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

Review 3.  The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.

Authors:  A Saven; L D Piro
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

4.  Evidence for separate carriers for purine nucleosides and for pyrimidine nucleosides in the renal brush border membrane.

Authors:  M Le Hir
Journal:  Ren Physiol Biochem       Date:  1990 May-Jun

5.  Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.

Authors:  B A Larder; A Kohli; S Bloor; S D Kemp; P R Harrigan; R T Schooley; J M Lange; K N Pennington; M H St Clair
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney.

Authors:  M M Gutierrez; K M Giacomini
Journal:  Biochim Biophys Acta       Date:  1993-07-04

7.  Mammalian nitrobenzylthioinosine-sensitive nucleoside transport proteins. Immunological evidence that transporters differing in size and inhibitor specificity share sequence homology.

Authors:  F Y Kwong; H E Fincham; A Davies; N Beaumont; P J Henderson; J D Young; S A Baldwin
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

8.  Expression of the rabbit intestinal N2 Na+/nucleoside transporter in Xenopus laevis oocytes.

Authors:  S M Jarvis; D A Griffith
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

Review 9.  Molecular manipulations of the multidrug transporter: a new role for transgenic mice.

Authors:  I Pastan; M C Willingham; M Gottesman
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

10.  Cloning and functional expression of a mammalian Na+/nucleoside cotransporter. A member of the SGLT family.

Authors:  A M Pajor; E M Wright
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  11 in total

1.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

Review 3.  Pharmacogenetics and pharmacoepigenetics of gemcitabine.

Authors:  M Candelaria; E de la Cruz-Hernández; E Pérez-Cárdenas; C Trejo-Becerril; O Gutiérrez-Hernández; A Dueñas-González
Journal:  Med Oncol       Date:  2009-11-10       Impact factor: 3.064

4.  Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues.

Authors:  D Herrera-Ruiz; Q Wang; O S Gudmundsson; T J Cook; R L Smith; T N Faria; G T Knipp
Journal:  AAPS PharmSci       Date:  2001

5.  Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters.

Authors:  J Lynge; C Juel; Y Hellsten
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

6.  Sodium dependence of nitrofurantoin active transport across mammary epithelia and effects of dipyridamole, nucleosides, and nucleobases.

Authors:  Phillip M Gerk; Linda Hanson; Margaret C Neville; Patrick J McNamara
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

7.  Hypoxanthine transport in human glioblastoma cells and effect on cell susceptibility to methotrexate.

Authors:  Wei Kong; Joanne Wang
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

8.  Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.

Authors:  Shuy-Vang Toan; Kenneth K W To; George P H Leung; Maria Olivia de Souza; Jeffrey L Ward; Chung-Ming Tse
Journal:  Pflugers Arch       Date:  2003-09-18       Impact factor: 3.657

9.  Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.

Authors:  Christopher J Endres; Dhruba J Sengupta; Jashvant D Unadkat
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

10.  Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.

Authors:  Andrea V Leisewitz; Eric I Zimmerman; Shannon Z Jones; Jing Yang; Lee M Graves
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-06       Impact factor: 1.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.